Berkeley Lights launches Opto Plasma B Discovery 4.0 workflow

By The Science Advisory Board staff writers

Berkeley Lights has launched its Opto Plasma B Discovery 4.0 workflow for antibody discovery which can advance from B cells to lead molecules in one week.

According to the company, the workflow can screen up to 100,000 cells and functionally test cells with highly sensitive cell-based assays. The workflow captures reexpressed molecules without the need for gene synthesis and bacterial cloning and increases the possibilities of success to access hard-to-hit targets.

The workflow uses the company's OptoSeq barcoded B-cell receptors, heavy and light chain antibody genes can be sequenced by DNA fragmentation, next-generation sequencing, and/or bioinformatics analysis. The results from the workflow can be integrated on the Berkeley Lights system to further accelerate candidates to market with antibody engineering and cell line development.

Copyright © 2021

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?